Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms?

Journal of Nuclear Medicine

Volumn 41, Issue 10, 2000, Pages 1702-1703

  Messa, C ^a   Landoni, C ^a   Pozzato, C ^a   Fazio, F ^a  

^a Medicina Nucleare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

BONE RESECTION; BONE SCINTISCANNING; BONE TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; MUSCLE TUMOR; MUSCULOSKELETAL DISEASE; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR LOCALIZATION;

BONE NEOPLASMS; FLUDEOXYGLUCOSE F 18; HUMAN; MUSCLE NEOPLASMS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033778853     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Overview by an oncologist: What are the imaging needs of the oncologist and oncological surgeon?
2. Evaluation and staging of musculoskeletal neoplasms
3. New developments in the staging and imaging of soft-tissue sarcomas
4. Grading of tumors and tumorlike lesions of bone: Evaluation by FDG PET
5. 18F PET
6. Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose
7. Metabolic imaging of human extremity musculoskeletal tumors
8. 18F]FDG
9. Fluorine-18-fluorodeoxyglucose PET imaging of soft tissue sarcoma
10. Benign versus malignant intraosseous lesions: Discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose
11. Chronic osteomyelitis: Detection with FDG-PET and correlation with histopathologic findings
12. Fluorine-18 FDG PET in Paget's disease of bone
13. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors
14. The role of nuclear medicine in primary bone and soft tissue tumors
15. PET evaluation of soft tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose
16. Monitoring of neoadjuvant therapy response of soft tissue and musculoskeletal sarcoma using fluorine-18-FDG PET
17. Evaluation of neoadjuvant response of osteogenic sarcoma using FDG PET
18. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT
19. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
20. Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET
21. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer
22. Staging of the axilla in breast cancer: An accurate in vivo assessment using positron emission tomograpby with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose
23. World Federation of Nuclear Medicine and Biology. 1999: Main diagnostic applications of nuclear medicine in oncology